Ironwood Pharmaceuticals, Inc. (IRWD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.27B |
| Enterprise value | 1.89B |
| Trailing P/E | 11.42 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.84 |
| Price/book (mrq) | 2.59 |
| Enterprise value/revenue | 4.27 |
| Enterprise value/EBITDA | -2.04 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.55 |
| 52-week change 3 | -22.26% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 15.70 |
| 52-week low 3 | 7.53 |
| 50-day moving average 3 | 9.92 |
| 200-day moving average 3 | 10.37 |
Share statistics
| Avg vol (3-month) 3 | 4.56M |
| Avg vol (10-day) 3 | 2.58M |
| Shares outstanding 5 | 156.53M |
| Implied shares outstanding 6 | 156.53M |
| Float 8 | 137.03M |
| % held by insiders 1 | 2.08% |
| % held by institutions 1 | 109.24% |
| Shares short (15 Apr 2024) 4 | 21.16M |
| Short ratio (15 Apr 2024) 4 | 5.44 |
| Short % of float (15 Apr 2024) 4 | 22.01% |
| Short % of shares outstanding (15 Apr 2024) 4 | 13.52% |
| Shares short (prior month 15 Mar 2024) 4 | 18.77M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1194:1000 |
| Last split date 3 | 02 Apr 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -226.37% |
| Operating margin (ttm) | 3.16% |
Management effectiveness
| Return on assets (ttm) | 13.39% |
| Return on equity (ttm) | -674.04% |
Income statement
| Revenue (ttm) | 442.74M |
| Revenue per share (ttm) | 2.85 |
| Quarterly revenue growth (yoy) | 9.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 169.91M |
| Net income avi to common (ttm) | -1B |
| Diluted EPS (ttm) | -6.45 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 92.15M |
| Total cash per share (mrq) | 0.59 |
| Total debt (mrq) | 715.54M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.85 |
| Book value per share (mrq) | -2.21 |
Cash flow statement
| Operating cash flow (ttm) | 183.43M |
| Levered free cash flow (ttm) | 186.79M |
© 2024 Yahoo. All rights reserved.